Nanjing Ruitian Pharmaceutical Technology

Nanjing Ruitian Pharmaceutical Technology is a specialized biotechnology company based in Nanjing, China, focusing on the development of advanced drug delivery systems. The company primarily excels in the research and industrialization of long-acting injectable formulations, including biodegradable microspheres and liposomes. Their portfolio includes improved versions of established drugs for treating central nervous system disorders, endocrine diseases, and various cancers. Ruitian operates as both a product developer and a service provider, offering CRO and CDMO capabilities for complex injectables. By utilizing its proprietary technology platforms, the company aims to enhance therapeutic outcomes and patient adherence through sustained-release mechanisms.